Kai has broad experience leading strategic engagements with clients across the life sciences industry, including big and small pharma/biopharma companies and investors. He has worked in all the major therapeutic areas, with a deep expertise in oncology / immuno-oncology, ophthalmology, neurology, and rare diseases. Kai works across the product and organizational life cycle, with a specific interest in business development and licensing support, asset and therapeutic area strategy, and growth strategy. In partnering with clients, Kai works to bring a content-driven strategic perspective, driving to grounded and actionable recommendations.
Kai has 5+ years of experience in life sciences-related research and consulting. Prior to joining ClearView, Kai studied the mechanisms of cell division at Yale as well as bone regeneration at UCSF. He received his B.S. in molecular and cell biology from Yale.
Debbi Amanti Belanger
Seth Berman
Klaus Bredl
Steven Chao
Rishi Dalsania
Kim Goh
Ketan Kapadia
Philip Kenner
Stuart MacGregor
David McClain
Richard Mynahan
Kevin Richard
Mike Rizzo
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Sidnee Pinho
Kristine Hyde
Jim Caruso
Steve Rubman
Lainey Miller
Brian Gibbs
Jonathan Betts
Dean Griffiths
Jonathan Hodgson
Slater Hurst
Dave Konciak
Charles Mathews
Rohit Kumar
Mike Roy
Beko Binder
Jessica Berard
Peter Goldman
Maneesh Gujrati
Austin Hubbert
Jonny Juliano
Owen Im
Andrew Kang
Patrick Kuettner
Joanna Lee
Alexander Lehrman
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Olivia Piccione
Matthew Pfister
Kai-Ming Pu
Sarah Stapleton
Kelsey Yardumian
Vini De Nadai